In PTC, the BRAF V600E mutation is reportedly associated with extrathyroidal extension, multifocality, advanced cancer stage, lymph node metastasis, and recurrence (37). This evidence concerns the gene BRAF and metastatic malignant neoplasm in the lymph nodes.